ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,975, issued on Sept. 22, was assigned to CMS RESEARCH & DEVELOPMENT PTE. LTD. (Singapore).

"Fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compound and use thereof" was invented by Kevin Chen (Shanghai), Boyu Hu (Shanghai), Kai Zhou (Shanghai), Zhaoguo Chen (Shanghai), Bin Liu (Shanghai), Guoping Hu (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are a series of fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compounds and the use thereof. Specifically disclosed are a compound represented by formula (H) and a pharm...